Deepak Khanna is President Europe & Canada for MSD, responsible for MSD’s Human Health business across this region. In this role he also represents MSD in the Patient Access Committee and the European Markets Committee at EFPIA, the European innovative pharmaceutical industry association.
Prior to his current role Mr. Khanna was SVP and Regional President EMEAC Oncology at MSD 2013-2020 leading commercial operations for MSD’s oncology business across Europe, Middle-East, Africa and Canada, and SVP and Managing Director of MSD in the UK and Ireland 2009-2013, a role which included the integration of MSD with Schering-Plough.
Alongside his role as Managing Director, he played an active role in pharmaceutical industry affairs in the UK. He held the position of President of the Association of the British Pharmaceutical Industry (ABPI) between April 2012 and April 2014 and oversaw the pricing and reimbursement negotiations with the UK government during his tenure.
Deepak Khanna began his career at MSD in 1988 in field sales and progressed to positions of increasing responsibility within the U.S. and Worldwide Human Health Division, leading to versatile leadership roles in multiple therapeutic areas. After MSD’s announcement on plans to merge with Schering-Plough, he also led the U.S. integration planning efforts.
Mr. Khanna has over 30 years of industry experience with broad functional expertise including strategic and operational roles across various geographies and divisions and is highly respected within the industry. He earned bachelor’s degree in biochemistry and economics from the University of California, Berkeley and an MBA in marketing from Santa Clara University.
Updated: June 2021